Delivery Order SPE2DB20D3104-SPE2DB25FW0J2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of VIBERZI 100 mg tablets (60-count). This $2,482.04 firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,762.43 by the Defense Logistics Agency on September 16, 2025, for the supply of VIBERZI 75 MG tablets (60 count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,707.60 for VIBERZI 75 mg tablets (60-count units), with an ultimate completion date of October 16, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and reflects AmerisourceBergen's role as a critical pharmaceutical supplier for federal medical procurement needs. The place of performance is listed as the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, on July 24, 2025, for the supply of Viberzi 100 mg tablets (60-count). This firm fixed price delivery order, valued at $1,184.87, is classified as a non-set-aside contract and is expected to reach ultimate completion by July 25, 2025, with performance occurring at AmerisourceBergen's Conshohocken...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Viberzi 100 mg tablets (60-count units) valued at $1,325.08. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,704.78 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count) with a firm fixed price arrangement. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Viberzi 75 mg tablets (60 count) valued at $2,354.21. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of VIBERZI 75 MG TABLET 60S, a pharmaceutical product, with a completion date of December 27, 2023 and a potential value of $1,134.46. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts to supply pharmaceuticals, medical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Viberzi 75 mg tablets (60-count units) with a ceiling value of $2,002.01. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,276.84 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count). This non-competitive, firm fixed-price delivery order is scheduled for completion by June 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, will fulfill this pharmaceutical...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FW0J2Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,276.84 for VIBERZI 100 mg tablets (60-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a broad range of pharmaceutical products, including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for VIBERZI, a specialty pharmaceutical treatment, exemplifies the company's ongoing role in supplying critical medications to Defense Health Agency customers and other federal healthcare systems through the DLA's flexible and comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/19/25 |